sa code of practice for the marketing of health products marketing ethics and what does this mean...
TRANSCRIPT
SA Code of Practice for the Marketing of Health Products
Marketing Ethics and what does this mean for an HCP?
Dr Haseena GaniExecutive OfficerSept 2013
Dr H Gani, Exec Officer, Sept 2013
2
Pharmaceutical Advertising Down But Definitely Not Out
Dr H Gani, Exec Officer, Sept 2013
3
Agenda Ethical Marketing & the Marketing Code of Practice?
Prescribing under the influence
Compliance – whose responsibility? What is ‘kosher’ in the Representative – HCP relationship?
HCPs independence
Enforcement structure & how can an HCP lodge a complaint?
The future
Dr H Gani, Exec Officer, Sept 2013
4
Marketing Ethics Ethics refers to the study of moral principles, or “right
and wrong” Marketing Ethics is all about marketers doing the
“right thing”. Exactly what the right thing is, is not always completely clear-cut
Principles involved in ethical marketing : Responsibility for their products and their
decisions. Honest and fair in their dealings with all
stakeholders. This means that products must be fit for use and accurately described, and contracts (both formal and implicit) should be drawn up in good faith and honoured;
Respecting consumer (patient) rights - including the right of redress, the right to information and the right to privacy
Dr H Gani, Exec Officer, Sept 2013
5
Special ethics risks in marketing health products Vulnerability of the target market –
safeguard the interests esp elderly & young
Knowledge gap between marketer & client – technical information
Ability to manipulate information What is said What is not said
Dr H Gani, Exec Officer, Sept 2013
6
Why does the healthcare industry need to promote medicines to HCPs? The industry has a legitimate right to promote
medicines to health professionals to ensure that they are up-to-date on the latest treatments available for patients. The availability of accurate, up-to-date information is vital to the appropriate use of medicines.
There must be a balance between the needs of patients, health professionals and the public, bearing in mind the political and social environment within which the industry operates and the statutory controls governing medicines.
Dr H Gani, Exec Officer, Sept 2013
7
Business Actions Toward Socially Responsible Marketing
Corporate marketing ethics policies Distributor relations, advertising standards,
customer service, pricing, product development and general ethical standards.
Guiding principle in policy determination
Free market and legal system
International ethical policies and Codes of Practice
Goal 4: Learn the role of ethics in marketing
Dr H Gani, Exec Officer, Sept 2013
8
Healthcare industry actions towards Ethical Marketing? In practice many companies and organisations
have attempted to deal with issues of marketing ethics by developing codes of conducts.
Legislative gaps globally to regulate this environment
The Marketing Code of Practice exists to help ensure that pharmaceutical companies operate in a responsible, ethical and professional manner when promoting medicines
Dr H Gani, Exec Officer, Sept 2013
9
Dr H Gani, Exec Officer, Sept 2013
10
What is the MCA? Marketing Code Authority Independent self regulatory
enforcement organisation for the Code Set up as legal entity (‘juristic body’) Members of the MCA are the
companies, not the trade associations Trade associations are key stakeholders
Dr H Gani, Exec Officer, Sept 2013
11
Ethics underpins the Code All that you do is values-based
Impacts on stakeholder interests Therefore you have ethical responsibilities
As individuals As communities / fraternities As organisations
In respect of ALL business activities including the marketing of health products
Code = expression of the underlying values & collective ethical responsibilities
Dr H Gani, Exec Officer, Sept 2013
12
Principles of the Code
Ethical marketing and promotion of
health products
Industry
image
Legal, regulatory
& professiona
l requiremen
ts
Independence of HCPs
Access to
products & info
Fair Competiti
on
Accurate informatio
n
Dr H Gani, Exec Officer, Sept 2013
13
Scope of the Code
Marketing Code• Innovative medicines
• Generic Medicines• Rx and OTC• Veterinary• Devices• In vitro diagnostics
Complementar
y medicines
Dr H Gani, Exec Officer, Sept 2013
14
Code Journey
Dr H Gani, Exec Officer, Sept 2013
15
A world first...
July 2007 – Marketing Steering Committee
2009 – SAMED & SALDA join
Feb 2010 – Interim Board of the MCA
Oct 2010 – Agreed version of the Code
May 2011 – Agreed MoU
Mar 2012 - Constitution
Dr H Gani, Exec Officer, Sept 2013
16
Recap - Legal context of the Code
Act 101 of 1965
Section 22G
Section 18C
Section 18B
Section 18A
Legal gaps identifiedCode will not resolve or eliminate issues around perversities in
the market
Makes provision for a Marketing
Code
Dr H Gani, Exec Officer, Sept 2013
17
Code and guidelines
• Marketing & promotion of health products to healthcare professionals
Part A
• Marketing & promotion of health products to consumersPart B
• Medical Devices & DiagnosticsPart C
• Code EnforcementPart D
Guidelines
Dr H Gani, Exec Officer, Sept 2013
18
Principles of the Code
Ethical marketing and promotion of
health products
Industry
image
Legal, regulatory
& professiona
l requiremen
ts
Independence of HCPs
Access to
products & info
Fair Competiti
on
Accurate informatio
n
Dr H Gani, Exec Officer, Sept 2013
19
The Healthcare Representative role A pharmaceutical sales representative is a key factor
within the sales of all drugs. They are responsible to ensure the healthcare
profession is informed of the benefits of the drug along with the safety and the side effects to assist a healthcare profession as the correct information and choices to prescribe medication.
The term used is ethical promotion, which can be described as communication of ethical values to promote their product to the physician. (Wright & Lundstrom, 2004)
Dr H Gani, Exec Officer, Sept 2013
20
Not a truth universally acknowledged Wealth of anecdotal evidence - paucity of studies
Do drug samples influence resident prescribing behavior? A randomized trial American Journal of Medicine, The Vol. 118, Issue 8, Pages 881-884
Scientific versus commercial sources of influence on the prescribing behavior of physicians American Journal of Medicine, The Vol. 73, Issue 1, Pages 4-8
Changes in drug prescribing patterns related to commercial company funding of continuing medical education. Journal of Continuing Education Health Professions, 8(1), 13-20. Bowman, M. A., & Pearle, D. L. (1988).
Prescribing under the influence?
Dr H Gani, Exec Officer, Sept 2013
21
HC Representatives do influence physician behaviour Søndergaard et al.: assess the impact of pharmaceutical
representatives on prescribing behaviour for a new fixed dose combination inhaled corticosteroid and long-acting β2-agonist (LABA) in Denmark.
Greater increase in the market share of the promoted fixed dose combination in those practices that received a visit in comparison to those that did not receive a visit.
It did not show an increase in the proportion of patients with asthma receiving inhaled steroids.
Principally about increasing market share. And not about increases in disease awareness and
appropriate prescribing; in this case, the supposition is that increased steroid prescriptions would represent such an effect.
Dr H Gani, Exec Officer, Sept 2013
22
At a time when many doctors are barring access to pharma reps, an August TNS Healthcare survey of 286 physicians: 40% of doctors surveyed see an improvement in
pharma sales interactions Improvement was seen in web-based physician
education and outreach 60% of physicians surveyed said that pharma-
sponsored physician education was useful to them Only 30% found corporate reputation to be critical,
although those who found it important said it was one of the most important factors
HC Representatives do influence physician behaviour & add value
Dr H Gani, Exec Officer, Sept 2013
23
Interactions with HCPsCompliance – whose responsibility is it?
Dr H Gani, Exec Officer, Sept 2013
24
Compliance – whose responsibility?
Dr H Gani, Exec Officer, Sept 2013
25
Compliance – whose responsibility?
Dr H Gani, Exec Officer, Sept 2013
26
What does the Code of Practice state on interactions with HCPs?
Dr H Gani, Exec Officer, Sept 2013
27
Healthcare representatives – what to do
Training of Healthcare Sales Representatives is the company’s responsibility
Compliance with codes and laws by Healthcare Sales Representatives
Gaining interviews : No inducement or subterfuge to gain an interview. Sales Representatives must not mislead as to their identity or the company that they represent.
Consideration for healthcare professionals and others
Information to scientific service of company (Adverse events)
Dr H Gani, Exec Officer, Sept 2013
28
CPD meetings
Companies, organisations or individuals are permitted to organise or sponsor meetings and events including Continuing Professional Development (CPD).
Dr H Gani, Exec Officer, Sept 2013
29
CPD meetings – points to consider
Hospitality/Venues of meetings and events (clause 17) The merit and focus of the meeting should be clearly
scientific and/or educational. No standalone entertainment
The venue and hospitality should be secondary to the meeting both in time allocation and focus
The venue should be appropriate and conducive to the scientific or educational objectives
Hospitality, meals and entertainment should be modest Invitations Honoraria Product promotion and using INN name of the product Reimbursement of acceptable costs eg travel Transparency and sponsorship declaration
Dr H Gani, Exec Officer, Sept 2013
30
Advertising & promotional material Post-registration by the MCC
All advertising and/or promotional material must be based on the current approved South African package insert
Information, claims and comparisons Accuracy, balance, fairness of claims. Exaggerated or misleading claims References & “data on file” Disparaging references – safety, quality and
efficacy High standards – suitability and taste Disguised promotion
Dr H Gani, Exec Officer, Sept 2013
31
Endorsements and testimonials by an HCP
The name or photograph or film of a member of a health profession must not be used in any way that is contrary to the applicable professional codes for that profession and all endorsements, where permitted by professional codes, have to be done within the scope of such codes
Testimonials shall comply with the approved package insert and with the other principles of this Code.
Testimonials should be less than three years old and be the genuine views of the user
Active ingredient not trade name has been prescribed (evidence to substantiate)
Dr H Gani, Exec Officer, Sept 2013
32
Consultancy Genuine consultancy underpinned by a
formal agreement
Declaration by the HCP
No direct payments to healthcare professionals for any other services
Dr H Gani, Exec Officer, Sept 2013
33
Gifts
Inexpensive and of minimal intrinsic value i.e. within the cost limit set from time to time per annum by the MCA
Not for personal use e.g. no entertainment CD’s/DVD’s, electronic items for entertainment, tickets to attend sporting events or other forms of entertainment.
Educational and/or of scientific value, benefit the patient and/or be relevant to the practice.
No cash or cash equivalents is allowed.
Cultural courtesy gifts
Dr H Gani, Exec Officer, Sept 2013
34
Other Competitions & prizes Donations to charity Corporate social responsibility
Dr H Gani, Exec Officer, Sept 2013
35
Principles of the Code
Ethical marketing and promotion of
health products
Industry
image
Legal, regulatory
& professiona
l requiremen
ts
Independence of HCPs
Access to
products & info
Fair Competiti
on
Accurate informatio
n
Dr H Gani, Exec Officer, Sept 2013
36
Declaration of HCP independence Unique role = able to bring the value of the big
hospital, the big pharmaceutical company, the big imaging device maker, and the big insurer all together at a single point for a particular person, the patient.
Rational and appropriate prescription – best interest of the patient
Critical thinking to analyse the source and content of information
Patient-centric approach Moral compass
Dr H Gani, Exec Officer, Sept 2013
37
Sources to sharpen HCPs skills Online resources, certification by
professional bodies Conferences Academic meetings Representative academic detailing vs sales Medical Science Liaisons Awareness of the Code, company policies,
international codes & regulations Professional Bodies’ Code of Conduct
Dr H Gani, Exec Officer, Sept 2013
38
We need your help - teamwork Our commitment to you = All companies
that comply with the Code are required to conduct themselves with honesty and integrity in all their dealings with you and to respect the spirit, as well as the letter, of the Code.
Your assistance in leveling the playing fields & achieving compliance
Dr H Gani, Exec Officer, Sept 2013
39
Majority of complaints are from HCPs… PMCPA (UK)
Dr H Gani, Exec Officer, Sept 2013
40
Code Enforcement
Dr H Gani, Exec Officer, Sept 2013
41
Principles
Transparency Fairness Defined timelines Opportunity for recourse
Dr H Gani, Exec Officer, Sept 2013
42
Enforcement Structure
MCA
Adjudicating Panel
Adjudicating
Committee
Appeal Panel
Appeal Committee
Legal Panel
Executive Officer
Appointed by
Board
Appointed by EO
for specific
complaint
43
Panels
PROCESS
Adjudication and Appeals = 34
Legal=8 Expertise in marketing,
medical & regulatory affairs
Good representation from the different sectors & independents
Briefing sessions Indemnity SLA – Formal relationship NDA/conflict of interest
prior to each matter
Dr H Gani, Exec Officer, Sept 2013
PANELS
Dr H Gani, Exec Officer, Sept 2013
44
Process flow for complaints
Company to company
Refer to MCA
Adjudication panel
Refer to MCA
Appeals panel
Final Sanction
no resolution no resolution
Legal Panel HCP/ Public lodge a complaint
Dr H Gani, Exec Officer, Sept 2013
45
Sanctions
• Minor• Moderate• Serious• Severe
• Fines not paid• Corrective Action not implemented
• Repeated Breaches• Multiple breaches• Invalid / unjustified / vexatious complaints
• Bringing the Code into disrepute
Breaches
• Immediate withdrawal of material/activity
• Written reprimand• Publication of corrective advertisement,
• Issue a corrective letter to healthcare professionals/public
Corrective Action
• R 6 - R300K• 30 -60 days
Fines / Timelines
Dr H Gani, Exec Officer, Sept 2013
46
Can HCPs be held to account for not acting ethically?
The Code only covers the industry’s activities. However, those interacting with industry as individuals or organisations also have a responsibility to ensure that their interactions comply with relevant legal & professional requirements.
Dr H Gani, Exec Officer, Sept 2013
47
Four Key Actions
Complaints Process2nd May
New edition of the Code
& GuidelinesMid - July
WebsiteQ3
CertificationEnd Q3
Dr H Gani, Exec Officer, Sept 2013
48
Dr H Gani, Exec Officer, Sept 2013
49
Thank you kindly...Any Questions